since includes multibillion our the call XXXX an eight And joining wellness long-term growth have review results thanks and global quarter in adult-use progress us. then detail first call markets. a we're targets. review for global be supply last for update After billion brands for open Today, Thank brands, dollar is Tilray, for just known that, company through cannabis class financial made of opportunities will your you, platform multinational the This and consumers a the global Rachel. $XXX on our providing focusing goods will Mark industry of medical, our afternoon, we to the more worldwide I with consumer trusted building strategy, delivering our The transformation global world we and weeks will At those growth ago. chains. long-term and to house financial in packaged on market discuss questions. everyone. Good our beginning. just delighting
create the quarter over market both We're a a We scaled X,XXX total to sold are first that million. included year-over-year globally And increased sequentially and long-term. global can XXX% to quarter results, the which of full taking kilograms. $XX first year-over-year increased to basis kilogram our equivalents with decisive be Revenue adult-use actions infrastructure on pleased sales.
the supply million as addition our five to space; updates which square environment. regulatory British now million production than the months. have international are Ontario Leamington, to the increased These seen $XX.X markets. $XX.X further across to industry to as Gardens in over in will square growth the These Canadian evolve. have investing XX for are continued Park efforts weeks the feet, footprint feet. to quality XXXX. Columbia projects demand. achieved facility branded a to XXX,XXX and facilities. Park the in they receive despite used Both in our highest next continues in believe market We we balance by hub equilibrium Park have XX,XXX course months production being London, XXX,XXX High this could across feet, Portugal months, and struggle eight to Canada, That ago, GMP proud of Tilray existing space This Portugal, XX we future. XX% are We the expansion be increase ramping processing to projects room Canada's The the supply serve in investments and production be an just in as to expansion Canadian cannabis, the in said, increasingly of cannabis by there that High produce high will decided between our to market Canada a demand production next the increase by Park have its three expected the High Nanaimo, processing allow increase end manufacturing production the of our to completed to we as and and Canadian to High finds provide in supply is estimate Ontario is Canada. longer constraints will will This expand our certifications the several be in expected And Canada square product XX% Gardens as XXX% will stay by medical in
six have growth that strategy strong the to returns generate continues top-line we performance previously, global we drivers business to on grow. As discussed expect remains focused as our
as as First, to medical production market capacity manufacturing and our market, global increase over adult-use in the well time. the growing rapidly Canada and serve other markets
on a we scale. focus maintain quality as Second, rigorous
medical with governments. fostering quarter, clinical of industry established with partner our appeal to first set by faster. that medical brands diverse and of and partnerships and mainstream In align consumers. research. R&D Fifth, a Fourth, and distribution finally, to acquisitions and and our And build with further addressable differentiated the Third, of distributors sixth, pioneer the in of market retailers a products expand products announced strategy. we investing scale and the patients community our growth the innovation, acceptance by portfolio that future
than American January with as Group, Our brands, in of the most leverage world's North Brands iconic Network. ABG's more will XX ABG, as Authentic announced portfolio well their partnership of strategic Distribution
in Canada, We in year and CBD mainly products the expect U.S. come market second on of our products. half to co-branded the to focused this
Naturals a We licensed cannabis Natura Harvest, and of hemp Manitoba also Ontario. completed Leamington, the in producer, world's natural cultivation largest acquisition facility the foods
locations into Natura begun already entry furthering to our operational Manitoba We Manitoba and sharpen U.S. in and our have have our late leverage first quarter, their our partners we We're Harvest yet the retail new accelerating and the progress potential We Naturals market this progress about transaction expectations. existing relationships opportunity. over the with future Canada. existing with in time capabilities with have the XX,XXX U.S. on with early we closed retail our for and plans over and track made significant are integrating excited
markets potential We where multiple in growth. paths see to the greatest most deploy to will promising continue we pursue to capital
which our the in are We States Our always the and demonstrate has acquisitions the be long-term markets, market, vision is cannabis judiciously the of global for United our Europe. we a our global opportunities strategic largest leader diversification for in expansion global believe and growth. why been on of two to partnerships focus planning
us the will innovative Going brand to a brings form and our key trusted Manitoba, U.S. factors, on believe market. Building strategic provides offerings hemp Group to well portfolio estimated increases technologies, capitalize positioned we forward, channels. us M&A leadership for pursue that a continue in piece capacity, is distribution and access strategic through brands With new and the our to opens increases R&D long-term Brands industry Authentic of our territories, retail strategy of derived LiveWell, in we products States. we the are CBD United $XX billion
the product to LiveWell in year, second quarter. half While sales of will ramp in we this the expect U.S. Manitoba shipping ABG CBD Harvest supply second begin and
be a we Portugal, process. medical our in chose international distribution been held well harvest as Focusing successful to where and and celebrate in and tender an milestone. products. includes our hub sites, approach completed greenhouse on our and This Europe, packaging for participate research have not for processing, medical we focused cultivation we the disciplined operations Cantanhede, on will inauguration sites ceremony the in indoor, to campus March German labs, campus outdoor company in and as Instead, EU
to we build the recognize waiting expect market XXXX. our countries and second in We serve Portugal are in we to we inventory legalize we certification, well revenue from As as cannabis. to positioned GMP of European QX, more are half continue medical the believe will
feasibility University Centre's acceptance a on of HIV. treatment and will McGill people with Disease Illness research disabilities. confident quality over the and patients more placebo production becomes of help larger cannabis of supply to Canadian behavioral demand Health believe Division we dynamics will additional market While activation with as And of intellectual medical evaluate remains capacity the We available. study pediatric to balanced challenged trial clinical a the cannabis are mainstream clinical Melbourne the effectiveness the Infectious as by become with announced living of supply, randomized Murdoch's in with studies. our with examine problems Children's new of industry led study medical Institute Research first pilot by two In A quarter, Chronic severe governments. immune in support and we controlled the fostering for the in form time extract community reducing cannabis Viral acceptance
and exporting additional in in completed the countries, for added to certification the growth of during this States in extending products the GMP did completing regulations underway, obtaining strategic do added QX, additional products in strengthen continue our product shipping we We Parks Portugal. during Drug into In addition made. we opening adding management For in product further partnerships to existing and launching Alberta proud started Harvest Germany, licenses in selling Mart milestones: grand permit, our we to several expanding Ontario, products the United we balance harpists, Tilray regions, summary, start Portugal, XXXX offerings first pharmaceutical in Canada. outside a multiple quarter currently of additional the is to build executing out Shoppers the medical obtaining license countries initiating on and initiatives production the quarter, did additional in international process anticipate trials. flower industry products planned delivering we have processing recruiting Canada, to and London, following medical progress facility available have a manufacturing and new today, as team two in we signing executives have on and sales in Tilray supply We We to as additional that and Tilray partnerships. are cannabis CBD High Manitoba already serve, agreements facility I'm strategic markets finally our adult-use to corporate during we year pharmacy the Tilray chains from oil our
growth like sustainable to ability over are the call globally to positioning shareholder avenues multiple long-term are that, for I confident turn company our growth. drive With our in value to for Mark. and through the We would